STRS Ohio’s Mirum Pharmaceuticals MIRM Stock Holding History

STRS Ohio’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.73M	Buy	14,800 +2,100	+17%	+$211K	0.01%	570
2026 Q1	$1.17M	Buy	12,700 +2,900	+30%	+$273K	﹤0.01%	672
2025 Q4	$774K	Sell	9,800 -2,900	-23%	-$208K	﹤0.01%	804
2025 Q3	$931K	Buy	12,700 +9,000	+243%	+$572K	﹤0.01%	714
2025 Q2	$188K	Sell	3,700 -8,500	-70%	-$378K	﹤0.01%	1684
2025 Q1	$550K	Buy	12,200 +6,000	+97%	+$283K	﹤0.01%	1121
2024 Q4	$256K	Buy	+6,200	New	+$258K	﹤0.01%	1421
2022 Q4	–	Sell	-10,200	Closed	-$214K	–	2037
2022 Q3	$214K	Hold	10,200	–	–	﹤0.01%	1589
2022 Q2	$198K	Buy	10,200 +600	+6%	+$14.2K	﹤0.01%	1613
2022 Q1	$211K	Hold	9,600	–	–	﹤0.01%	1695
2021 Q4	$153K	Hold	9,600	–	–	﹤0.01%	1804
2021 Q3	$191K	Sell	9,600 -4,000	-29%	-$65.1K	﹤0.01%	1785
2021 Q2	$235K	Buy	13,600 +1,300	+11%	+$23.3K	﹤0.01%	1768
2021 Q1	$243K	Hold	12,300	–	–	﹤0.01%	1764
2020 Q4	$214K	Hold	12,300	–	–	﹤0.01%	1724
2020 Q3	$237K	Buy	12,300 +11,600	+1,657%	+$249K	﹤0.01%	1623
2020 Q2	$13K	Hold	700	–	–	﹤0.01%	2080
2020 Q1	$9K	Hold	700	–	–	﹤0.01%	1945
2019 Q4	$17K	Buy	+700	New	+$7.46K	﹤0.01%	1990

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

STRS Ohio's MIRM Position: Q2 2026 in Review

STRS Ohio increased its Mirum Pharmaceuticals (MIRM) stake by 17% in Q2 2026, buying an estimated $211K and bringing the position to 14,800 shares worth $1.73M. The position accounts for 0.01% of the portfolio, ranked #570.

STRS Ohio first reported a position in MIRM in Q4 2019 and has held it in 19 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

STRS Ohio held 14,800 shares of Mirum Pharmaceuticals worth $1.73M as of Q2 2026.
STRS Ohio bought 2,100 Mirum Pharmaceuticals shares in Q2 2026, an estimated $211K.
Mirum Pharmaceuticals made up 0.01% of STRS Ohio's portfolio in Q2 2026, its #570 holding.
STRS Ohio first reported a position in Mirum Pharmaceuticals in Q4 2019 and has held it in 19 quarters since.
327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.